137 related articles for article (PubMed ID: 35736369)
1. [The risks of tanning with the Barbie drug].
Eijmael MJPM; Janmaat CJ; Briët-Schipper EMN
Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736369
[TBL] [Abstract][Full Text] [Related]
2. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
Nelson ME; Bryant SM; Aks SE
Clin Toxicol (Phila); 2012 Dec; 50(10):1169-73. PubMed ID: 23121206
[TBL] [Abstract][Full Text] [Related]
3. Atypical melanocytic naevi following melanotan injection.
Reid C; Fitzgerald T; Fabre A; Kirby B
Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
[TBL] [Abstract][Full Text] [Related]
4. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?
Langan EA; Nie Z; Rhodes LE
Br J Dermatol; 2010 Sep; 163(3):451-5. PubMed ID: 20545686
[TBL] [Abstract][Full Text] [Related]
5. A glimpse into the underground market of melanotan.
Callaghan Iii DJ
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142729
[TBL] [Abstract][Full Text] [Related]
6. An in-depth case examination of an exotic dancer's experience of melanotan.
Van Hout MC; Brennan R
Int J Drug Policy; 2014 May; 25(3):444-50. PubMed ID: 24280586
[TBL] [Abstract][Full Text] [Related]
7. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Gilhooley E; Daly S; McKenna D
Dermatology; 2021; 237(6):995-999. PubMed ID: 34464955
[TBL] [Abstract][Full Text] [Related]
8. [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
Burian E; Burian E
Lakartidningen; 2013 Jan 30-Feb 5; 110(5):208-10. PubMed ID: 23451671
[No Abstract] [Full Text] [Related]
9. Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans.
Dorr RT; Dvorakova K; Brooks C; Lines R; Levine N; Schram K; Miketova P; Hruby V; Alberts DS
Photochem Photobiol; 2000 Oct; 72(4):526-32. PubMed ID: 11045725
[TBL] [Abstract][Full Text] [Related]
10. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
Habbema L; Halk AB; Neumann M; Bergman W
Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
[TBL] [Abstract][Full Text] [Related]
11. [The Barbie drug melanotan--new internet drug with risky consequences].
Knudsen K; Kjergaard C; Dalhoff K
Lakartidningen; 2012 Oct 17-23; 109(42):1895-6. PubMed ID: 23193937
[No Abstract] [Full Text] [Related]
12. Melanotan Tanning Injection: A Rare Cause of Priapism.
Mallory CW; Lopategui DM; Cordon BH
Sex Med; 2021 Feb; 9(1):100298. PubMed ID: 33460908
[TBL] [Abstract][Full Text] [Related]
13. Melanoma associated with the use of melanotan-II.
Hjuler KF; Lorentzen HF
Dermatology; 2014; 228(1):34-6. PubMed ID: 24355990
[TBL] [Abstract][Full Text] [Related]
14. Melanotan-associated melanoma in situ.
Ong S; Bowling J
Australas J Dermatol; 2012 Nov; 53(4):301-2. PubMed ID: 22724573
[TBL] [Abstract][Full Text] [Related]
15. [Self-tanning and sunless tanning products].
Martini MC
Ann Dermatol Venereol; 2017 Oct; 144(10):638-644. PubMed ID: 28823805
[TBL] [Abstract][Full Text] [Related]
16. Melanotan II: a possible cause of renal infarction: review of the literature and case report.
Peters B; Hadimeri H; Wahlberg R; Afghahi H
CEN Case Rep; 2020 May; 9(2):159-161. PubMed ID: 31953620
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.
Breindahl T; Evans-Brown M; Hindersson P; McVeigh J; Bellis M; Stensballe A; Kimergård A
Drug Test Anal; 2015 Feb; 7(2):164-72. PubMed ID: 24771717
[TBL] [Abstract][Full Text] [Related]
18. Update on tanning: More risks, fewer benefits.
O'Leary RE; Diehl J; Levins PC
J Am Acad Dermatol; 2014 Mar; 70(3):562-8. PubMed ID: 24388421
[TBL] [Abstract][Full Text] [Related]
19. [Undesirable pigmentation].
Bayerl C
Hautarzt; 2015 Oct; 66(10):757-63. PubMed ID: 26315100
[TBL] [Abstract][Full Text] [Related]
20. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.
Dorr RT; Ertl G; Levine N; Brooks C; Bangert JL; Powell MB; Humphrey S; Alberts DS
Arch Dermatol; 2004 Jul; 140(7):827-35. PubMed ID: 15262693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
